Penumbra Denmark ApS is a Danish APS based in Silkeborg, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 2023, the company has 6 employees and reported a gross profit of DKK 18.5m in its latest annual filing.
In its most recent annual report (2025), Penumbra Denmark ApS reported a gross profit of DKK 18.5m, an increase of 28% on the year before. The figures on this page draw on 3 annual filings covering 2023 to 2025. The bottom line showed a net profit of DKK 1.6m, and the EBITDA margin stood at 11.5%.
At the end of 2025, equity financed 83.1% of the balance sheet, and current assets covered short-term debt 5.9 times.